Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study

JL Saes; MJ Verhagen; K Meijer; Marjon Cnossen; REG Schutgens; M Peters; L Nieuwenhuizen; FJ van der Meer; IC Kruis; WL van Heerde; SEM Schols

doi:10.1182/bloodadvances.2020002740

Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study

JL Saes, MJ Verhagen, K Meijer, Marjon Cnossen, REG Schutgens, M Peters, L Nieuwenhuizen, FJ van der Meer, IC Kruis, WL van Heerde, SEM Schols

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	English
Pages (from-to)	5025-5034
Number of pages	10
Journal	Blood advances
Volume	4
Issue number	20
DOIs	https://doi.org/10.1182/bloodadvances.2020002740
Publication status	Published - 2020

Research programs

EMC MM-02-54-03

Access to Document

10.1182/bloodadvances.2020002740

http://hdl.handle.net/1765/131611

Cite this

@article{cda5c444797a41839ed5caeab3bf80c3,

title = "Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study",

author = "JL Saes and MJ Verhagen and K Meijer and Marjon Cnossen and REG Schutgens and M Peters and L Nieuwenhuizen and {van der Meer}, FJ and IC Kruis and {van Heerde}, WL and SEM Schols",

year = "2020",

doi = "10.1182/bloodadvances.2020002740",

language = "English",

volume = "4",

pages = "5025--5034",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "20",

}

TY - JOUR

T1 - Bleeding severity in patients with rare bleeding disorders: real-life data from the RBiN study

AU - Saes, JL

AU - Verhagen, MJ

AU - Meijer, K

AU - Cnossen, Marjon

AU - Schutgens, REG

AU - Peters, M

AU - Nieuwenhuizen, L

AU - van der Meer, FJ

AU - Kruis, IC

AU - van Heerde, WL

AU - Schols, SEM

PY - 2020

Y1 - 2020

U2 - 10.1182/bloodadvances.2020002740

DO - 10.1182/bloodadvances.2020002740

M3 - Article

C2 - 33064819

SN - 2473-9529

VL - 4

SP - 5025

EP - 5034

JO - Blood advances

JF - Blood advances

IS - 20

ER -